Coborn's Pharmacy Slapped with Fine
Jennifer Lewerenz | Jun 11, 2019 AT 2:58 pm
(KNSI) - Coborn's Pharmacy is being hit with a $225,000 fine for failing to comply with record keeping and other requirements of the Controlled Substances Act, which enabled a Coborn’s Pharmacy employee to engage in a years-long pattern of diverting opioids for personal use.
A press release from the U.S. Attorney's Office says between 2011 and 2015, the pharmacy did not adequately monitor its employee’s conduct, and failed to keep complete and accurate records regarding the receipt and dispensing of controlled substances, including but not limited to oxycodone and hydrocodone.
These alleged violations enabled the pharmacist in charge of one of the retail stores to fabricate nine patient accounts and create numerous false prescriptions. The fakes were then recorded on the store's computerized prescription management system. The U.S. Attorney's Office also says Coborn's system did not consistently identify and process cash prescriptions, failing to prevent the diversion that occurred. As a result of the alleged actions, hundreds of doses of controlled substances went unaccounted for and were illegally diverted, mostly for what the U.S. Attorney's Office says was personal use by the pharmacist in charge.
A press release says Coborn's immediately reported the incidents as soon as they became aware, and informed the Drug Enforcement Agency.
The pharmacist in charge pleaded guilty to fraud, and the pharmacy says they have since beefed up record keeping and compliance programs.
The claims resolved by the settlement are allegations only; there has been no determination of liability.